Modular Pharma Factories: The Next Step for Continuous Manufacturing?
Discover how modular pharmaceutical manufacturing and continuous production could improve flexibility, resilience, and efficiency across modern pharmaceutical operations.
Learn about manufacturing, supply chain optimisation and quality systems across pharmaceutical operations.
Discover how modular pharmaceutical manufacturing and continuous production could improve flexibility, resilience, and efficiency across modern pharmaceutical operations.
Discover why AI in cell and gene therapy is necessary for successful development by improving drug discovery, viral vector engineering, manufacturing, and quality control.
Cell and gene therapy CMC strategies, quality systems, and manufacturing innovation are critical to advanced therapy development and determine scalability.
Discover how innovations in AAV vector manufacturing are improving scalability, quality, and commercial readiness for next-generation gene therapies.
Discover how next-generation sequencing in cell line development is improving biologics manufacturing, quality control, and regulatory confidence.
Europe's 2026 heatwave is pushing pharmaceutical cold chain risk to the limit. Here is what supply chain leaders must do to protect drug integrity now.
ICH E6(R3) raises the governance bar for CRO and vendor oversight in clinical trials. Here's what sponsors must build into outsourcing relationships to protect trial quality and timelines.
Continuous pharmaceutical manufacturing cuts production time by up to 90% and is now backed by ICH Q13. Here’s what manufacturing leaders need to know about the shift to CM.
Find out how Quality-by-Design improves reliability and compliance in pharma and how you can maximise innovation through quality-based pharma development systems.
Regulatory leadership is no longer just compliance. In this episode of Chain Reaction, Dineshree Naiker explains why early regulatory strategy, supply chain governance, and value-based thinking are critical to improving patient access and healthcare outcomes.
COVID-19 exposed major weaknesses in pharmaceutical supply chains. In this episode of Chain Reaction, Trisha Pillay and Émile Malan explore how AI, regulatory reform, and local manufacturing could strengthen healthcare resilience.
Geopolitical risk is reshaping how clinical supply chains are managed, demanding resilience and foresight. Learn why building supply chain resilience is the key for clinical trial success.